Cargando…
ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803796/ https://www.ncbi.nlm.nih.gov/pubmed/20021692 http://dx.doi.org/10.1186/1471-2202-10-150 |
_version_ | 1782176073854746624 |
---|---|
author | Krämer, Ulrike M Rojo, Nuria Schüle, Rebecca Cunillera, Toni Schöls, Ludger Marco-Pallarés, Josep Cucurell, David Camara, Estela Rodriguez-Fornells, Antoni Münte, Thomas F |
author_facet | Krämer, Ulrike M Rojo, Nuria Schüle, Rebecca Cunillera, Toni Schöls, Ludger Marco-Pallarés, Josep Cucurell, David Camara, Estela Rodriguez-Fornells, Antoni Münte, Thomas F |
author_sort | Krämer, Ulrike M |
collection | PubMed |
description | BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number of tandem repeats (VNTR) polymorphism in exon III of this gene is suggested to bear a higher risk for ADHD. In the present study, we investigated the role of this polymorphism in the modulation of neurophysiological correlates of response inhibition (Go/Nogo task) in a healthy, high-functioning sample. RESULTS: Homozygous 7 repeat carriers showed a tendency for more accurate behavior in the Go/Nogo task compared to homozygous 4 repeat carriers. Moreover, 7 repeat carriers presented an increased nogo-related theta band response together with a reduced go-related beta decrease. CONCLUSIONS: These data point to improved cognitive functions and prefrontal control in the 7 repeat carriers, probably due to the D4 receptor's modulatory role in prefrontal areas. The results are discussed with respect to previous behavioral data on this polymorphism and animal studies on the impact of the D4 receptor on cognitive functions. |
format | Text |
id | pubmed-2803796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28037962010-01-10 ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample Krämer, Ulrike M Rojo, Nuria Schüle, Rebecca Cunillera, Toni Schöls, Ludger Marco-Pallarés, Josep Cucurell, David Camara, Estela Rodriguez-Fornells, Antoni Münte, Thomas F BMC Neurosci Research article BACKGROUND: Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number of tandem repeats (VNTR) polymorphism in exon III of this gene is suggested to bear a higher risk for ADHD. In the present study, we investigated the role of this polymorphism in the modulation of neurophysiological correlates of response inhibition (Go/Nogo task) in a healthy, high-functioning sample. RESULTS: Homozygous 7 repeat carriers showed a tendency for more accurate behavior in the Go/Nogo task compared to homozygous 4 repeat carriers. Moreover, 7 repeat carriers presented an increased nogo-related theta band response together with a reduced go-related beta decrease. CONCLUSIONS: These data point to improved cognitive functions and prefrontal control in the 7 repeat carriers, probably due to the D4 receptor's modulatory role in prefrontal areas. The results are discussed with respect to previous behavioral data on this polymorphism and animal studies on the impact of the D4 receptor on cognitive functions. BioMed Central 2009-12-20 /pmc/articles/PMC2803796/ /pubmed/20021692 http://dx.doi.org/10.1186/1471-2202-10-150 Text en Copyright ©2009 Krämer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article Krämer, Ulrike M Rojo, Nuria Schüle, Rebecca Cunillera, Toni Schöls, Ludger Marco-Pallarés, Josep Cucurell, David Camara, Estela Rodriguez-Fornells, Antoni Münte, Thomas F ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title | ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title_full | ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title_fullStr | ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title_full_unstemmed | ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title_short | ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample |
title_sort | adhd candidate gene (drd4 exon iii) affects inhibitory control in a healthy sample |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803796/ https://www.ncbi.nlm.nih.gov/pubmed/20021692 http://dx.doi.org/10.1186/1471-2202-10-150 |
work_keys_str_mv | AT kramerulrikem adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT rojonuria adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT schulerebecca adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT cunilleratoni adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT scholsludger adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT marcopallaresjosep adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT cucurelldavid adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT camaraestela adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT rodriguezfornellsantoni adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample AT muntethomasf adhdcandidategenedrd4exoniiiaffectsinhibitorycontrolinahealthysample |